PNC Financial Services Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.1M | Sell |
537,599
-442
| -0.1% | -$36.4K | 0.02% | 309 |
|
|
2025
Q4 | $45.9M | Sell |
538,041
-13,007
| -2% | -$1.07M | 0.03% | 294 |
|
|
2025
Q3 | $42.9M | Sell |
551,048
-15,439
| -3% | -$1.21M | 0.03% | 304 |
|
|
2025
Q2 | $44.3M | Sell |
566,487
-14,592
| -3% | -$1.09M | 0.03% | 292 |
|
|
2025
Q1 | $42.1M | Sell |
581,079
-23,499
| -4% | -$1.68M | 0.02% | 289 |
|
|
2024
Q4 | $44.8M | Sell |
604,578
-29,364
| -5% | -$2.06M | 0.03% | 277 |
|
|
2024
Q3 | $41.8M | Sell |
633,942
-22,824
| -3% | -$1.66M | 0.03% | 295 |
|
|
2024
Q2 | $60.7M | Sell |
656,766
-9,876
| -1% | -$875K | 0.04% | 236 |
|
|
2024
Q1 | $63.7M | Sell |
666,642
-10,609
| -2% | -$891K | 0.04% | 232 |
|
|
2023
Q4 | $51.6M | Sell |
677,251
-44,738
| -6% | -$3.11M | 0.04% | 250 |
|
|
2023
Q3 | $50M | Sell |
721,989
-30,015
| -4% | -$2.41M | 0.04% | 246 |
|
|
2023
Q2 | $70.9M | Sell |
752,004
-28,724
| -4% | -$2.5M | 0.06% | 207 |
|
|
2023
Q1 | $64.6M | Sell |
780,728
-208
| -0% | -$16.4K | 0.06% | 216 |
|
|
2022
Q4 | $58.3M | Sell |
780,936
-13,843
| -2% | -$1.07M | 0.06% | 225 |
|
|
2022
Q3 | $65.7M | Sell |
794,779
-20,942
| -3% | -$2.02M | 0.07% | 199 |
|
|
2022
Q2 | $77.6M | Sell |
815,721
-33,614
| -4% | -$3.48M | 0.08% | 187 |
|
|
2022
Q1 | $100M | Sell |
849,335
-13,099
| -2% | -$1.47M | 0.09% | 174 |
|
|
2021
Q4 | $112M | Sell |
862,434
-10,236
| -1% | -$1.19M | 0.09% | 167 |
|
|
2021
Q3 | $98.8M | Sell |
872,670
-5,518
| -0.6% | -$630K | 0.09% | 170 |
|
|
2021
Q2 | $91M | Sell |
878,188
-25,676
| -3% | -$2.42M | 0.08% | 180 |
|
|
2021
Q1 | $75.6M | Sell |
903,864
-527,268
| -37% | -$44.6M | 0.07% | 193 |
|
|
2020
Q4 | $131M | Sell |
1,431,132
-9,190
| -0.6% | -$762K | 0.13% | 142 |
|
|
2020
Q3 | $115M | Sell |
1,440,322
-15,484
| -1% | -$1.21M | 0.14% | 145 |
|
|
2020
Q2 | $101M | Sell |
1,455,806
-73,141
| -5% | -$5.2M | 0.13% | 157 |
|
|
2020
Q1 | $96.1M | Sell |
1,528,947
-40,263
| -3% | -$2.9M | 0.12% | 151 |
|
|
2019
Q4 | $122M | Sell |
1,569,210
-36,330
| -2% | -$2.84M | 0.12% | 152 |
|
|
2019
Q3 | $118M | Buy |
1,605,540
+539,187
| +51% | +$37.9M | 0.12% | 152 |
|
|
2019
Q2 | $65.7M | Sell |
1,066,353
-31,749
| -3% | -$1.92M | 0.06% | 203 |
|
|
2019
Q1 | $70M | Sell |
1,098,102
-51,282
| -4% | -$2.93M | 0.07% | 192 |
|
|
2018
Q4 | $58.7M | Sell |
1,149,384
-37,866
| -3% | -$1.92M | 0.07% | 203 |
|
|
2018
Q3 | $68.9M | Sell |
1,187,250
-36,888
| -3% | -$1.8M | 0.07% | 200 |
|
|
2018
Q2 | $59.4M | Sell |
1,224,138
-111,834
| -8% | -$5.22M | 0.06% | 221 |
|
|
2018
Q1 | $62.1M | Sell |
1,335,972
-215,733
| -14% | -$9.37M | 0.06% | 217 |
|
|
2017
Q4 | $58.3M | Sell |
1,551,705
-2,038,527
| -57% | -$74.8M | 0.06% | 231 |
|
|
2017
Q3 | $131M | Sell |
3,590,232
-84,870
| -2% | -$3.24M | 0.14% | 141 |
|
|
2017
Q2 | $145M | Sell |
3,675,102
-969
| -0% | -$35.4K | 0.16% | 130 |
|
|
2017
Q1 | $115M | Sell |
3,676,071
-237,087
| -6% | -$7.42M | 0.13% | 153 |
|
|
2016
Q4 | $122M | Sell |
3,913,158
-148,530
| -4% | -$4.81M | 0.14% | 143 |
|
|
2016
Q3 | $163M | Sell |
4,061,688
-186,036
| -4% | -$7.01M | 0.19% | 106 |
|
|
2016
Q2 | $141M | Sell |
4,247,724
-1,657,929
| -28% | -$56.7M | 0.17% | 127 |
|
|
2016
Q1 | $174M | Buy |
5,905,653
+205,749
| +4% | +$5.68M | 0.2% | 99 |
|
|
2015
Q4 | $150M | Sell |
5,699,904
-28,056
| -0.5% | -$729K | 0.18% | 120 |
|
|
2015
Q3 | $136M | Buy |
5,727,960
+283,836
| +5% | +$6.85M | 0.16% | 128 |
|
|
2015
Q2 | $129M | Buy |
5,444,124
+915,384
| +20% | +$20.7M | 0.14% | 140 |
|
|
2015
Q1 | $108M | Buy |
4,528,740
+3,114,738
| +220% | +$69.9M | 0.12% | 151 |
|
|
2014
Q4 | $30M | Buy |
1,414,002
+211,038
| +18% | +$4.24M | 0.03% | 305 |
|
|
2014
Q3 | $20.5M | Buy |
1,202,964
+659,514
| +121% | +$10.4M | 0.02% | 360 |
|
|
2014
Q2 | $7.78M | Buy |
543,450
+416,628
| +329% | +$5.65M | 0.01% | 537 |
|
|
2014
Q1 | $1.57M | Sell |
126,822
-5,976
| -5% | -$69K | ﹤0.01% | 922 |
|
|
2013
Q4 | $1.46M | Sell |
132,798
-2,322
| -2% | -$26.2K | ﹤0.01% | 913 |
|
|
2013
Q3 | $1.57M | Sell |
135,120
-5,838
| -4% | -$68.3K | ﹤0.01% | 878 |
|
|
2013
Q2 | $1.58M | Buy |
+140,958
| New | +$1.67M | ﹤0.01% | 852 |
|
Other funds holding EW
VCM
VPM
PNC Financial Services Group's EW Position: Q1 2026 in Review
PNC Financial Services Group reduced its Edwards Lifesciences (EW) stake by 0.08% in Q1 2026, selling an estimated $36.4K and leaving 537,599 shares worth $43.1M. The position accounts for 0.02% of the portfolio, ranked #309.
PNC Financial Services Group first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q1 2016. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- PNC Financial Services Group held 537,599 shares of Edwards Lifesciences worth $43.1M as of Q1 2026.
- PNC Financial Services Group sold 442 Edwards Lifesciences shares in Q1 2026, an estimated $36.4K.
- Edwards Lifesciences made up 0.02% of PNC Financial Services Group's portfolio in Q1 2026, its #309 holding.
- PNC Financial Services Group first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- PNC Financial Services Group's Edwards Lifesciences position peaked at $174M in Q1 2016.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.